Dae Ho Lee

Activation of the AXL kinase causes resistance to EGFR-targeted therapy in lung cancer

Zhenfeng Zhang, Jae Cheol Lee, Luping Lin et al. · Nature Genetics · 2012 · 1.2K citations · Full text

Oncology, Axl Kinase, Egfr-targeted Therapy +8

Extranodal Natural Killer T-Cell Lymphoma, Nasal-Type: A Prognostic Model From a Retrospective Multicenter Study

Jeeyun Lee, Cheolwon Suh, Young Hyeh Ko et al. · Journal of Clinical Oncology · 2005 · 609 citations · Full text

Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study

Byoung Chul Cho, Delvys Rodríguez‐Abreu, Maen Hussein et al. · The Lancet Oncology · 2022 · 399 citations · Full text

Comprehensive Analysis of<i>UGT1A</i>Polymorphisms Predictive for Pharmacokinetics and Treatment Outcome in Patients With Non–Small-Cell Lung Cancer Treated With Irinotecan and Cisplatin

Ji‐Youn Han, Hyeong‐Seok Lim, Eun‐Soon Shin et al. · Journal of Clinical Oncology · 2006 · 298 citations · Full text

Switchable Transparency and Wetting of Elastomeric Smart Windows

Seung Goo Lee, Dong Yun Lee, Ho Sun Lim et al. · Advanced Materials · 2010 · 295 citations